News
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.
Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Travis Barker's Playboy bombshell ex Shanna Moakler showed off her slimmer-than-ever frame in a bikini as she posed with ...
Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...
Serena Williams Reveals Her Weight Loss Journey: After Kids, GLP-1s Were “A Medicine My Body Needed”
In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...
Novo Nordisk (NYSE: NVO) is a Danish pharma heavyweight currently trading at undervalued levels, presenting an attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results